EyePoint Pharmaceuticals, Inc. — Director's Dealing 2017

Dec 27, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2017-12-22

Reporting Person: Ross Leonard S (See Remarks)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-12-22	Restricted Stock Units	$	A	62892	Acquired		Common Stock (62892)	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2: The restricted stock units will vest in full on December 22, 2018 and the vested shares will be delivered to the reporting person within 30 days following the vesting date.